Company Monitoring Page for Cyclacel

latest headlines for company on cafepharma

After nearly 20 years, Cyclacel kicks phase 3 leukemia drug back to Daiichi
Fierce Biotech
Thu, 11/10/22 - 10:39 am
Tags:
Cyclacel, AML, Sapacitabine, Daiichi Sankyo
5 biotech CEOs on payers, investors and big bets
BioPharma Dive
Fri, 03/10/17 - 09:42 am
Tags:
biotech, payers, investors, Gil Van Bokkelen, Athersys, Robert McNeil, DalCor Pharmaceuticals, Pierre Belichard, Enterome, Michael Metzger, Syndax, Spiro Rombotis, Cyclacel
The Worst-Performing Biotech Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:36 pm
Tags:
biotech, Nymox, Elbit, PhotoMedex, Sophiris Bio, WaferGen Bio-systems, Nanosphere, Cyclacel, MELA Sciences, Cytori, Regado Biosciences, BioLife Solutions
With Or Without You Cyclacel Is Going To Rise
Seeking Alpha
Sun, 09/8/13 - 11:06 am
Tags:
Cyclacel
Cyclacel says Celgene will buy 4 patents related to Istodax for $5.5M, resolving lawsuits
Yahoo/AP
Thu, 04/4/13 - 09:25 am
Tags:
Istodax, Cyclacel, Celgene, patents
Cyclacel Explained: Answers About The Long Misunderstood And Undervalued Biotech
Seeking Alpha
Thu, 01/24/13 - 06:43 pm
Tags:
Cyclacel
Will Cyclacel Pharmaceuticals’ Pipeline Be a Success?
Wall St. Cheat Sheet
Wed, 12/5/12 - 10:23 am
Tags:
Cyclacel, Sapacitabine
Upcoming AML Treatments - Which Company Will Fly?
Seeking Alpha
Mon, 12/3/12 - 10:49 am
Tags:
AML, Celgene, Cyclacel, Sunesis, acute myeloid leukemia
Why These 3 Biotech Stocks Are Winning
Motley Fool
Sat, 10/27/12 - 11:32 am
Tags:
Cyclacel, Gilead Sciences, Amarin
Cyclacel Heats Up On Clinical Trial Progression
Seeking Alpha
Wed, 10/17/12 - 11:56 am
Tags:
Cyclacel, Sapacitabine, myelodysplastic syndrome
4 Cash Loaded Biotech Stocks With Little Debt
Seeking Alpha
Thu, 08/30/12 - 09:48 am
Tags:
Obagi Medical Products, Cyclacel, Vanda, 3SBio
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Mon, 05/28/12 - 11:21 am
Tags:
ASCO, Synta, Sunesis, Arqule, Cyclacel, Aveo, Bristol-Myers Squibb
Cyclacel: An Intriguing Long Shot
Seeking Alpha
Tue, 03/20/12 - 10:35 am
Tags:
Cyclacel, Sapacitabine, cancer, Daiichi Sankyo
Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash
TheStreet.com
Fri, 03/2/12 - 10:10 am
Tags:
Cyclacel, Vivus, Celldex, Astex, Discovery Labs, Exelixis
BIO CEO Conference Live Blog
TheStreet.com
Mon, 02/13/12 - 10:30 am
Tags:
BIO CEO Conference, Celsion, Cyclacel, Navidea Biopharmaceuticals, Chelsea Therapeutics, Titan, Galena Biopharma, Oxigene
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) Remains as Far from FDA Approval as Ever Despite Recommendation from DSMB
OTC Equity
Sat, 10/15/11 - 01:11 pm
Tags:
Cyclacel, Sapacitabine, acute myeloid leukemia, leukemia
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Tags:
Achillion, Aeterna Zentaris, Antigenics, Ariad, Amylin, Amarin, BioDelivery Sciences, Cyclacel, Geron, Dendreon, PharmAthene, Zalicus, Human Genome Sciences, Keryx, Peregrine Pharmaceuticals, SIGA technologies, YM BioSciences
Cyclacel Pharmaceuticals: A Little Left on the Upside
Seeking Alpha
Mon, 05/16/11 - 11:57 am
Tags:
Cyclacel, earnings
3 Late-Stage Leukemia Company Previews for ASCO 2011
Seeking Alpha
Mon, 05/9/11 - 10:31 am
Tags:
ASCO, leukemia, Celgene, Cyclacel, Sunesis, Supergen, Eisai
Cyclacel rallies on drug update
Marketwatch
Fri, 12/3/10 - 11:04 am
Tags:
Cyclacel, Sapacitabine, MDS

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.